Vaccine News and Research

Latest Vaccine News and Research

Wisconsin has identified its first laboratory confirmed case of influenza this season

Public health officials in the department said the case, confirmed by the Wisconsin State Laboratory of Hygiene to be influenza type A (H3 subtype), involves an adult female from Waupaca County.

13 Oct 2004

MedImmune progresses development of Respiratory Syncytial Virus and Parainfluenza Virus Type-3 vaccines

MedImmune has announced that data from a preclinical study for its lead vaccine candidate to prevent respiratory syncytial virus (RSV) and parainfluenza virus type-3 (PIV-3) has shown a protective immune response against both viruses in animals.

13 Oct 2004

California issues alert and warning about flu vaccine price gouging

California State Attorney General Bill Lockyer has urged consumers and pharmacists to provide his office information about price gouging by flu vaccine suppliers and warned he will take enforcement action against those who exploit the supply shortage by charging unconscionable prices.

13 Oct 2004

FDA and MHRA to cooperate efforts to address manufacturing concerns related Chiron's influenza vaccine

The FDA and the U.K's MHRA have announced their intent to continue in a cooperative effort to address the manufacturing quality concerns related to the production of Chiron's influenza vaccine, Fluvirin, at the company's Liverpool facility.

13 Oct 2004

Influenza expert is beginning a three-year direct comparison of flu shots versus nasal spray flu vaccine

Flu shots have been around since World War II, and the Centers for Disease Control and Prevention has long recommended shots as a way to prevent influenza in the elderly. The approval of a new nasal spray vaccine begs the question whether those looking to stave off the flu should stick with the tried and true injection or switch to the nasal spray.

13 Oct 2004

CDC and Aventis Pasteur plan to allocate influenza vaccine

The Centers for Disease Control and Prevention (CDC) and Aventis Pasteur announced today the first phase of the plan to allocate influenza vaccine in response to the recently announced loss of half of the nation’s expected flu vaccine supply for the 2004-2005 season.

12 Oct 2004

New study offers rare glimpse of how the smallpox virus attacks its victims

Results of a new study in monkeys offer scientists a rare glimpse of how, on a molecular level, the smallpox virus attacks its victims. The findings shed light on how the virus caused mass death and suffering, and will help point the way to new diagnostics, vaccines and drugs that would be needed in the event of a smallpox bioterror incident.

12 Oct 2004

Study finds new vaccine against pneumococcal has minor adverse effects but continued surveillance is warranted

Examination of reports from the first two years after licensure of a new vaccine against pneumococcal infections indicates that the majority of adverse effects are minor, but that continued surveillance is warranted, according to a study in the October 13 issue of JAMA.

12 Oct 2004

A change in the national polio vaccination policy has led to the elimination of vaccine-associated paralytic poliomyelitis

The researchers found that from 1990 through 1999, 61 cases of paralytic polio were reported; 59 (97 percent) of these were VAPP (1 case per 2.9 million OPV doses distributed), 1 case was imported, and 1 case was indeterminate.

12 Oct 2004

Health care providers need to work together to ensure that high-risk individuals get the flu shot

Dr. Eric E. Whitaker, Illinois state public health director, is encouraging health care providers to work together to ensure that high-risk individuals get the flu shot.

11 Oct 2004

Results do not suggest widespread anthrax antibiotic abuse in the aftermath of the 2001 terrorist attacks

Prescriptions for antibiotics that could be taken in advance to prevent against anthrax were uncommon among concerned patients after September 11, 2001 and the 2001 U.S. anthrax attacks, according to an article in the October 11 issue of The Archives of Internal Medicine.

11 Oct 2004

Pharmacists respond to unprecedented demand for the flu vaccine in the wake of the current shortage

Pharmacists are responding to unprecedented demand for the flu vaccine in the wake of the current shortage. The pharmacist is on the front line in addressing consumers’ questions and concerns about the availability of the vaccine and in helping Americans understand the CDC’s priorities for administration of the immunization.

10 Oct 2004

HHS awards contracts totaling more than $232 million to fund development of new vaccines against smallpox, plague and tularemia

United States Department of Health and Human Services has announced four new contracts totaling more than $232 million to fund development of new vaccines against three potential agents of bioterrorism: smallpox, plague and tularemia. The National Institute of Allergy and Infectious Diseases (NIAID), will administer the contracts.

8 Oct 2004

Flu vaccine shortage highlights need to accelerate the approval of affordable generic biopharmaceuticals and vaccines

Following the announcement that the nation is facing a flu vaccine shortage this year, the Generic Pharmaceutical Association (GPhA) renewed its call for the Food and Drug Administration (FDA) and Congress to move forward to accelerate the approval of affordable generic biopharmaceuticals and vaccines.

8 Oct 2004

Global under-five death rate far below targets agreed to by world leaders

New country-by-country data reveals alarmingly slow progress on reducing child deaths despite the availability of proven, low-cost interventions, a UNICEF survey revealed today.

8 Oct 2004

Discovery of a central memory form of helper T cells that can offer immunity to leishmaniasis

Researchers at the University of Pennsylvania have discovered a "central memory" form of "helper" T cells that can offer immunity to leishmaniasis, a disease that causes considerable death and disfigurement across the globe and has been found in U.S. military personnel returning from Afghanistan and Iraq.

8 Oct 2004

Britain's Chief Medical Officer has announced new measures to tackle and eliminate tuberculosis in Britain

The Plan, Stopping Tuberculosis in England, provides a strong commitment to tackle the disease by increasing the awareness of the disease amongst health professional and the public, establishing high quality surveillance to monitor the disease concentrating on high risk groups, identifying the infection early, and ensuring excellence in clinical care for patients with TB.

7 Oct 2004

Indiana health officials are appealing to health care providers to limit use of this year’s diminished supply of flu vaccine

Indiana State health officials are appealing to health care providers to limit use of this year’s diminished supply of flu vaccine to immunizing people at high risk from complications of influenza.

6 Oct 2004

Influenza is a contagious disease caused by an RNA virus of the orthomyxoviridae family

Influenza (or as it is commonly known, the flu) is a contagious disease caused by an RNA virus of the orthomyxoviridae family (The orthomyxoviridae is a family of RNA viruses which infect vertebrate).

6 Oct 2004

Expert says it is unlikely bird flu will reach Canada

United Nations officials warn the outbreak of bird flu is far from over and continues to spread in Thailand and Vietnam. An expert at The University of Western Ontario says it is unlikely the disease will reach Canada but travellers should take precautions.

5 Oct 2004

Vaccine News and Research

Latest Vaccine News and Research

Wisconsin has identified its first laboratory confirmed case of influenza this season

MedImmune progresses development of Respiratory Syncytial Virus and Parainfluenza Virus Type-3 vaccines

California issues alert and warning about flu vaccine price gouging

FDA and MHRA to cooperate efforts to address manufacturing concerns related Chiron's influenza vaccine

Influenza expert is beginning a three-year direct comparison of flu shots versus nasal spray flu vaccine

CDC and Aventis Pasteur plan to allocate influenza vaccine

New study offers rare glimpse of how the smallpox virus attacks its victims

Study finds new vaccine against pneumococcal has minor adverse effects but continued surveillance is warranted

A change in the national polio vaccination policy has led to the elimination of vaccine-associated paralytic poliomyelitis

Health care providers need to work together to ensure that high-risk individuals get the flu shot

Results do not suggest widespread anthrax antibiotic abuse in the aftermath of the 2001 terrorist attacks

Pharmacists respond to unprecedented demand for the flu vaccine in the wake of the current shortage

HHS awards contracts totaling more than $232 million to fund development of new vaccines against smallpox, plague and tularemia

Flu vaccine shortage highlights need to accelerate the approval of affordable generic biopharmaceuticals and vaccines

Global under-five death rate far below targets agreed to by world leaders

Discovery of a central memory form of helper T cells that can offer immunity to leishmaniasis

Britain's Chief Medical Officer has announced new measures to tackle and eliminate tuberculosis in Britain

Indiana health officials are appealing to health care providers to limit use of this year’s diminished supply of flu vaccine

Influenza is a contagious disease caused by an RNA virus of the orthomyxoviridae family

Expert says it is unlikely bird flu will reach Canada

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Vaccine News and Research

Latest Vaccine News and Research

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Newsletters you may be interested in